Fig. 5
a, c Representative T1WI and T2WI of 4T1 tumor-bearing mouse at axial planes after intravenous injection of different samples and b, d ∆SNR analysis corresponding to a, c, respectively. Tumor region are marked by white dotted lines. e color-coded T1 and T2 map images, f corresponding T1 map value, and g T2 map values of 4T1 tumor-bearing mice treated with PDGFB-FMS at the presence of GSH or GSH inhibitor (LBS)